ArticleJournal of thoracic disease2026
A multidisciplinary comfort-enhanced recovery after surgery program improves perioperative patient-reported outcomes after lung cancer surgery: a randomized controlled trial.
Article in Journal of thoracic disease, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Association of postoperative orthostatic intolerance with early recovery quality and clinical outcomes following thoracoscopic pulmonary resection: a propensity-matched study.Journal of thoracic disease · 2026Article
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Patients undergoing lung cancer surgery frequently experience postoperative discomfort. Although enhanced recovery after surgery (ERAS) effectively reduces length of stay and complications, patients' subjective comfort is often underaddressed. The aim of this study is to evaluate the impact of a comfort-enhanced recovery after surgery (ComERAS) protocol on perioperative comfort, quality of life (QoL), and patient satisfaction among surgical lung cancer patients. Methods: A single-center, single-blind, randomized controlled trial design was employed. Patients were randomly assigned at a 1:1 ratio to the ComERAS group or the standard ERAS group. The ComERAS group received personalized comfort management provided by a multidisciplinary team, including preemptive multimodal analgesia, a "minimal-tube" strategy, early mobilization, traditional Chinese medicine interventions, and psychological support. Primary outcomes were General Comfort Questionnaire (GCQ) scores at discharge (T1). Secondary outcomes included GCQ score at 1 month postoperatively (T2), QoL, anxiety, depression and patient satisfaction. Analyses followed the intention-to-treat principle. Results: There were 134 participants randomized and 121 participants completed the 1-month follow-up. Compared with the ERAS group, the ComERAS group had significantly higher overall comfort scores at discharge (+1.05, P=0.01) and at 1 month (+0.57, P=0.006), improved self-care ability, and lower symptom burdens related to cough, pain, sleep, and fatigue (P<0.05). Moreover, the ComERAS group improved emotional function, overall QoL, and patient satisfaction (P<0.05). Conclusions: The ComERAS protocol significantly improved perioperative comfort, emotional function, QoL, and patient satisfaction during the first postoperative month in patients after lung cancer surgery. These findings offer empirical evidence and a practical framework for shifting perioperative care from a "medicine-centered" to a "patient-experience-centered" approach. While supporting the immediate value of prioritizing comfort, further studies on extended follow-up and multicenter validation are warranted. Trial Registration: Chinese Clinical Trial Registry ChiCTR2500109153.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.